|
|
It is important that you keep up with the
changes that occur daily in the world of HIV, so you can educate
yourself about these changes and discuss them with your healthcare
provider.
COPAID, in combination with other antiretroviral agents, is
indicated for the treatment of HIV-1 infection in adults.
Composition
(abacavir sulfate and lamivudine)
Each tablet contains
abacavir sulfate.... 600mg
lamivudine................300 mg
Indication and Usage
COPAID, in combination with other antiretroviral agents, is
indicated for the treatment of HIV-1 infection in adults.
COPAID is one of 3 medicines containing abacavir. Before starting
COPAID, your healthcare professional will review your medical
history in order to avoid the use of abacavir if you have
experienced a hypersensitivity reaction to abacavir in the past.
In one study, more patients had a severe hypersensitivity reaction
in the abacavir once-daily group than in the abacavir twice-daily
group.
COPAID should not be used as part of a triple-nucleoside regimen.
COPAID does not cure HIV infection/AIDS or prevent passing HIV to
others.
Important Safety Information
COPAID contains abacavir, which is also contained in ZIAVIR® (abacavir
sulfate) and TRIIVIR® (abacavir sulfate, lamivudine, and
zidovudine). Patients taking COPAID may have a serious allergic
reaction (hypersensitivity reaction) that can cause death.
If you get a symptom from 2 or more of the following groups while
taking COPAID, stop taking COPAID and call your doctor right away.
Abacavir and lamivudine, two medications that have been used for
years to treat HIV infection, are available as COPAID. Take one
COPAID Tablet once a day as part of your HIV combination regimen.
COPAID has no food or fluid requirements.
Information contained within this Web site does not cover all
possible uses, actions, warnings, precautions, side effects, or
interactions of COPAID™ (which contains abacavir sulfate and
lamivudine) with other medicines you may take.
If you have questions about the information provided, ask your
healthcare professional. More information, written in technical
medical language for healthcare professionals, is available. You
can request this information from your healthcare professional.
COPAID, in combination with other antiretroviral agents, is
indicated for the treatment of HIV-1 infection in adults.
COPAID is one of 3 medicines containing abacavir. Before starting
COPAID, your healthcare professional will review your medical
history in order to avoid the use of abacavir if you have
experienced a hypersensitivity reaction to abacavir in the past.
In one study, more patients had a severe hypersensitivity reaction
in the abacavir once-daily group than in the abacavir twice-daily
group.
COPAID should not be used as part of a triple nucleoside regimen.
COPAID does not cure HIV infection/AIDS or prevent passing HIV to
others.
What’s the most important information I should know about taking
COPAID?
COPAID contains abacavir, which is also contained in ZIAGEN® (abacavir
sulfate) and TRIZIVIR® (abacavir sulfate, lamivudine, and
zidovudine). Patients taking COPAID may have a serious allergic
reaction (hypersensitivity reaction) that can cause death.
If you get a symptom from 2 or more of the following groups while
taking COPAID, stop taking COPAID and call your doctor right away.
Symptom(s)
Group 1 Fever
Group 2 Rash
Group 3 Nausea, vomiting, diarrhea, or abdominal (stomach area)
pain
Group 4 Generally ill feeling, extreme tiredness, or achiness
Group 5 Shortness of breath, or sore throat
Read the list of problems that can happen on the Warning Card that
your pharmacist gives you. Carry the Warning Card with you.
If you stop COPAID because you have had an allergic reaction to
abacavir, NEVER take COPAID or another abacavir-containing
medicine (ZIAVIR® and TRIIVIR®) again. If you take COPAID or
another abacavir-containing medicine again after you have had an
allergic reaction, WITHIN HOURS you may get life-threatening
symptoms that may include very low blood pressure or death.
If you stop COPAID for any other reason, even for a few days, and
you are not allergic to COPAID, talk with your healthcare
professional before taking it again. Taking COPAID again can cause
a serious or life-threatening reaction, even if you never had an
allergic reaction before. If your healthcare professional tells
you that you can take COPAID again, start taking it when you are
around medical help or people who can call a doctor if you need
one.
What other safety information should I know about COPAID™ (abacavir
sulfate and lamivudine)?
COPAID, like other HIV medicines, can cause a condition called
lactic acidosis and severe liver problems. Lactic acidosis occurs
when acid builds up in the blood, which can affect how the body
functions. In some cases, lactic acidosis can cause death. Nausea
and tiredness that don’t get better may be symptoms of lactic
acidosis. Women are more likely than men to get this serious side
effect.
Patients with hepatitis B virus (HBV) infection, who take COPAID
and then stop it, may get "flare-ups" of their hepatitis. A
"flare-up" is when the disease suddenly returns in a worse way
than before. If you have HBV infection, your doctor should closely
monitor your liver function for several months after stopping
COPAID. You may need to take anti-HBV medicines.
Worsening of liver disease (sometimes resulting in death) has
occurred in patients infected with both HIV and hepatitis C virus
who are taking anti-HIV medicines and are also being treated for
hepatitis C with interferon with or without ribavirin. If you are
taking COPAID as well as interferon with or without ribavirin and
you experienc side effects, be sure to tell your doctor.
When you start taking HIV medicine, your immune system may get
stronger and could begin to fight infections that have been hidden
in your body, such as pneumonia, herpes virus or tuberculosis. If
you have new symptoms after starting your HIV medicine, be sure to
tell your doctor.
Changes in body fat may occur in some patients taking
antiretroviral therapy. These changes may include an increased
amount of fat in the upper back and neck ("buffalo hump"), breast,
and around the trunk. Loss of fat from the legs, arms, and face
may also occur. The cause and long-term health effects of these
conditions are not known at this time.
The most common side effects seen with COPAID were allergic
reaction, trouble sleeping, depression, headache, tiredness,
dizziness, nausea, diarrhea, rash, fever, stomach pain, abnormal
dreams, and anxiety. Most of these side effects did not cause
people to stop taking this combination of medicines in clinical
studies.
These are not all the side effects you could have when taking this
medicine. Your healthcare professional can discuss a full list of
side effects with COPAID.
Presentation
COPAID KIT
|